english.prescrire.org > Annual Prescrire Awards > The Prescrire Awards for 2007 > The 2007 Prescrire Awards for Drugs, Packaging and Information > The 2007 Prescrire Drug Awards

The Prescrire Awards for 2007

The 2007 Prescrire Awards for Drugs, Packaging and Information

The 2007 Prescrire Drug Awards

The Prescrire Drug Awards focus on products evaluated during the previous year in the New Products section of our French edition (issues 279 to 290 in 2007).

PILULE D'OR / GOLDEN PILL
The "Golden Pill" award is granted to drugs that provide a major therapeutic advance in a field in which no effective treatment was previously available.
carglumic acid CARBAGLU°
Orphan Europe		 Five years of follow-up of about 20 patients showed that oral carglumic acid ensures normal long-term survival of children with a rare fatal urea cycle disorder (Prescrire International
n° 94)
HONOURS LIST
The following drugs (in alphabetical order of international nonproprietary names) provide a clear advantage for some patients, in comparison to existing therapeutic options, albeit with certain limitations:
imatinib GLIVEC°
Novartis		 Chronic myeloid leukaemia (with longer follow-up) (la revue Prescrire n° 290)
trastuzumab HERCEPTIN°
Roche		 Adjuvant treatment of some forms of breast cancer (Prescrire International n° 89)
NOTEWORTHY
The following drugs (in alphabetical order of international nonproprietary names) made a modest contribution to patient care:
artemether + lumefantrin RIAMET°
Novartis		 Treatment of uncomplicated Plasmodium falciparum malaria attacks (Prescrire International n° 94)
darunavir PREZISTA°
Janssen-Cilag		 HIV infection after failure of multiple antiretroviral drug regimens (la revue Prescrire n° 289)
levetiracetam KEPPRA°
UCB		 Myoclonic epilepsy from age 12 years (la revue Prescrire n° 287)
methotrexate MÉTHOTREXATE BELLON°
Sanofi Aventis		 Psoriatic rheumatism (Prescrire International n° 91)
triamcinolone
(hexacetonide)
(intra-articular)
 HEXATRIONE°
Daiichi Sankyo		 Juvenile idiopathic arthritis (Prescrire International n° 92)
papillomavirus 6,11,16,18 vaccine GARDASIL°
Sanofi Pasteur MSD		 Prevention of high-grade cervical dysplasia (Prescrire International n° 89)
SPECIAL MENTION
meningococcal B vaccine strain 44/76 MenBvac° Approved under exceptional circumstances by the French Health Ministry and manufactured by the Norwegian National Institute of Public Health (la revue Prescrire n° 288).
©Prescrire April 2008
Source: Prescrire Int 2008; 17 (94): 75.